Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
life sciences
medicare
3
×
national blog main
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
amgen
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
diagnostics
immunotherapy
indiana blog main
indiana top stories
merck
national
national top stories
new york blog main
new york top stories
novartis
pfizer
president trump
raleigh-durham blog main
raleigh-durham top stories
roche
seattle blog main
seattle top stories
sickle cell disease
spark therapeutics
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
What
drug
3
×
patients
3
×
bio
roundup
acquisitions
advantages
albert
bar
biggest
bourla
brings
ceo
company
crispr
daunting
developers
expect
firms
future
gamble
healthcare
imports
maker
maps
market
markets
maze
measured
medco’s
mindmaze
mover
new
payers
pfizer
pfizer’s
physical
physicians
plan
policies
present
Language
unknown
unset
Current search:
drug
×
patients
×
" boston blog main "
×
medicare
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets